M&A Deal Summary

Alora Acquires Osmotica Pharmaceuticals - Legacy Business

On June 25, 2021, Alora acquired life science company Osmotica Pharmaceuticals - Legacy Business from RVL Pharmaceuticals for 170M USD

Acquisition Highlights
  • This is Alora’s 1st transaction in the Life Science sector.
  • This is Alora’s largest (disclosed) transaction.
  • This is Alora’s 1st transaction in the United States.
  • This is Alora’s 1st transaction in New Jersey.

M&A Deal Summary
Date 2021-06-25
Target Osmotica Pharmaceuticals - Legacy Business
Sector Life Science
Buyer(s) Alora
Sellers(s) RVL Pharmaceuticals
Deal Type Divestiture
Deal Value 170M USD

Target

Osmotica Pharmaceuticals - Legacy Business

Bridgewater, New Jersey, United States
Osmotica Pharmaceuticals' Legacy Business gives a diverse portfolio and dedication to high-quality branded and generic products focused on ophthalmology and aesthetics

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Alora

Alpharetta, Georgia, United States
Category Company
Founded 2011
Sector Life Science
DESCRIPTION

Alora develops and manufactures pharmaceuticals, including prenatal vitamins, nutraceuticals, dermatologics and innovative products for gastroenterology and endocrinology disorders. Alora maintains a broad portfolio of both branded and non-branded products, focusing on identifying opportunities to acquire and enhance the market potential of commercially available dietary supplement products and late-stage development drugs to fulfill unmet medical and dietary needs. Alora was founded in 2011 and is based in Alpharetta, Georgia.

DEAL STATS #
Overall 1 of 2
Sector (Life Science) 1 of 2
Type (Divestiture) 1 of 1
State (New Jersey) 1 of 1
Country (United States) 1 of 2
Year (2021) 1 of 1
Size (of disclosed) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-01-10 Monarch PCM

Fort Worth, Texas, United States

Monarch PCM is a pharmaceutical contract manufacturer. Monarch PCM was founded in 2015 and is based in Fort Worth, Texas.

Buy -

Seller(S) 1

SELLER

RVL Pharmaceuticals

Bridgewater, New Jersey, United States
Category Company
Sector Life Science
Employees125
Revenue 50M USD (2022)
DESCRIPTION

RVL Pharmaceuticals is a fully-integrated specialty pharmaceutical and generics company with capabilities across the pharmaceutical lifecycle. With an attractive portfolio of marketed products and robust pipeline, RVL Pharmaceuticals develops, manufactures and commercializes pharmaceutical products across a variety of therapeutic areas, including neuroscience, pain and women’s healthcare. RVL Pharmaceuticals is based in Bridgewater, New Jersey.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (New Jersey) 1 of 1
Country (United States) 1 of 1
Year (2021) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-12-04 Vertical Pharmaceuticals

Sayreville, New Jersey, United States

Vertical / Trigen is a specialty pharmaceutical company engaged in the development, marketing, and distribution of both branded and generic prescription pharmaceuticals in the United States. Vertical, the segment of the company focused on branded pharmaceuticals, specializes in women’s health, pain management, and respiratory and allergy medications.

Buy -
Mergr

Product

Company

Legal